Filana Therapeutics Inc.

FLNA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.62

-$0.04 (-5.78%)

At close: Oct 30, 2026, 4:00 PM ET

$0.65

+$0.03 (+4.84%)

Pre-market: Nov 2, 2026, 4:05 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-5.78%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

-3.0 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #971/1028 (Top 94%)

Full Analysis

Key Statistics

Market Data

Market Cap $30.05M

1D Range

0.62 0.66

52W Range

0.61 2.45

Valuation (TTM)

PE -0.71

PB 0.47

EV/EBITDA 1.25

Valuation (NTM)

Forward PE 15.67

Forward PEG 0.01

Price Target $0.00

Cash Flow

FCF Yield -105.7%

SBC Adj. FCF Yield -120.4%

SBC Impact -13.9%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 11.7% | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA -40.7%

ROE -58.8%

ROIC -72.1%

Financial Health

Net Cash

$82.68M

Current Ratio 2.08

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzhe...

Sector Healthcare

Industry Biotechnology

Employees 19

IPO Date Jul 14, 2000

Website www.filanatx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.